Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

GeoVax Labs, Inc. - Common Stock (NQ: GOVX )

2.100 -0.120 (-5.41%)
Streaming Delayed Price Updated: 12:03 PM EST, Jan 22, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 218,113
Open 2.220
Bid (Size) 2.100 (7)
Ask (Size) 2.110 (6)
Prev. Close 2.220
Today's Range 2.100 - 2.221
52wk Range 1.090 - 11.18
Shares Outstanding 2,172,309
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
GeoVax Announces Major Gedeptin Milestone With Plans of Phase 2 Trial
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Exposures Product Safety
GeoVax Announces Major Gedeptin Milestone With Plans of Phase 2 Trial
Represents a Key Step Toward Validating Gedeptin Potential in Solid Tumor Therapy 
Via TheNewswire.com
Exposures Product Safety

Performance

YTD
-15.32%
-15.32%
1 Month
-4.98%
-4.98%
3 Month
+1.94%
+1.94%
6 Month
-20.45%
-20.45%
1 Year
-51.41%
-51.41%

More News

Read More
GeoVax Achieves Significant Progress in Next-Generation COVID-19 Vaccine Development Throughout 2024
Via NewMediaWire
Exposures COVID-19
GeoVax Achieves Significant Progress in Next-Generation COVID-19 Vaccine Development Throughout 2024
Via TheNewswire.com
Exposures COVID-19
GeoVax to Review 2024 Progress at the Emerging Growth Conference on January 16, 2025
Via NewMediaWire
Exposures COVID-19
GeoVax to Review 2024 Progress at the Emerging Growth Conference on January 16, 2025
Via TheNewswire.com
Exposures COVID-19
Earnings Scheduled For November 12, 2024
Via Benzinga
Earnings Preview: Geovax Labs
Via Benzinga
GeoVax to Review 2024 Progress at Biotech Showcase During J.P. Morgan Healthcare Week 2025
Via NewMediaWire
GeoVax to Review 2024 Progress at Biotech Showcase During J.P. Morgan Healthcare Week 2025
Via TheNewswire.com
3 Penny Stocks Ready to Break Out in 2025
Via MarketBeat
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
This GeoVax Labs Analyst Begins Coverage On A Bullish Note; Here Are Top Initiations For Monday
Via Benzinga
David Dodd, CEO of GeoVax Labs Inc. (NASDAQ: GOVX), to Present at NobleCon20
Via Investor Brand Network
EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In September 2024 – Where Do Tesla, Nvidia, Apple, DJT Stock Rank?
Via Benzinga
GeoVax to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference
Via NewMediaWire
EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In August 2024 – Where Do Tesla, Nvidia, Apple, AMD Stock Rank?
Via Benzinga
GeoVax to Participate in Upcoming Investor Conferences in September
Via NewMediaWire
GeoVax to Raise Approximately $5.0 Million of Gross Proceeds in Offering Priced At-the-Market
Via NewMediaWire
WHO Seeks $135M In Funding To Fight Mpox: Outbreak 'Can Be Controlled, And Can Be Stopped'
Via Benzinga
Snowflake, GeoVax, Zoom, Target, Tesla: Why These 5 Stocks Are On Investors' Radars Today
Via Benzinga
Topics Stocks
Exposures US Equities
GeoVax Labs Stock Surges Ahead Of The Close, Shares Remain Volatile: What's Happening?
Via Benzinga
BioMedNewsBreaks — GeoVax Labs Inc. (NASDAQ: GOVX) Enters $8.5M Registered Direct Offering with Institutional Investor
Via Investor Brand Network
Exposures COVID-19
Registration is Now Open for Tribe Public's Webinar Event "Now Is Not the Time to Monkey(pox) Around" Featuring GeoVax Labs CEO
Via NewMediaWire
GeoVax Stock Is Tumbling Tuesday: What's Going On?
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.